Maravai LifeSciences (MRVI) Short Interest Ratio & Short Volume $2.25 -0.15 (-6.25%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.27 +0.02 (+1.07%) As of 05/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Maravai LifeSciences Short Interest DataMaravai LifeSciences (MRVI) has a short interest of 14.24 million shares. This marks a 2.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 2.35 million shares to cover all short positions.Current Short Interest14,240,000 sharesPrevious Short Interest13,950,000 sharesChange Vs. Previous Month+2.08%Dollar Volume Sold Short$28.76 millionShort Interest Ratio4.4 Days to CoverLast Record DateApril 30, 2025Outstanding Shares254,660,000 sharesPercentage of Shares Shorted5.59%Today's Trading Volume2,428,954 sharesAverage Trading Volume2,352,123 sharesToday's Volume Vs. Average103% Short Selling Maravai LifeSciences? Sign up to receive the latest short interest report for Maravai LifeSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRVI Short Interest Over TimeMRVI Days to Cover Over TimeMRVI Percentage of Float Shorted Over Time Maravai LifeSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202514,240,000 shares $28.76 million +2.1%N/A4.4 $2.02 4/15/202513,950,000 shares $24.13 million +6.3%5.6%4.2 $1.73 3/31/202513,130,000 shares $29.02 million +13.2%5.2%3.9 $2.21 3/15/202511,600,000 shares $28.42 million +31.5%4.6%3.8 $2.45 2/28/20258,820,000 shares $28.40 million -14.4%3.5%3.3 $3.22 2/15/202510,300,000 shares $43.26 million +20.6%4.1%4.4 $4.20 1/31/20258,540,000 shares $42.10 million -4.3%N/A4.1 $4.93 1/15/20258,920,000 shares $40.68 million +4.8%N/A4.5 $4.56 12/31/20248,510,000 shares $46.38 million +2.7%N/A4.5 $5.45 12/15/20248,290,000 shares $47.00 million +4.9%N/A4.7 $5.67 Get the Latest News and Ratings for MRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maravai LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,900,000 shares $44.79 million +13.5%N/A4.4 $5.67 11/15/20246,960,000 shares $30.76 million -15.3%N/A3.8 $4.42 10/31/20248,220,000 shares $60.91 million -8.4%N/A4 $7.41 10/15/20248,970,000 shares $74.36 million -2.7%N/A4.6 $8.29 9/30/20249,220,000 shares $76.62 million +16.6%N/A4.5 $8.31 9/15/20247,910,000 shares $66.36 million -5.6%N/A3.3 $8.39 8/31/20248,380,000 shares $75.84 million -0.7%N/A3.6 $9.05 8/15/20248,440,000 shares $67.27 million +6.6%N/A3.5 $7.97 7/31/20247,920,000 shares $77.06 million -1.9%7.2%3.7 $9.73 7/15/20248,070,000 shares $70.69 million +17.3%7.4%3.8 $8.76 6/30/20246,880,000 shares $49.26 million +11.3%6.3%3.3 $7.16 6/15/20246,180,000 shares $46.47 million +0.8%5.6%3.1 $7.52 5/31/20246,130,000 shares $53.15 million -9.1%5.6%2.8 $8.67 5/15/20246,740,000 shares $75.49 million -5.5%6.2%2.6 $11.20 4/30/20247,130,000 shares $58.47 million +12.5%6.7%2.6 $8.20 4/15/20246,340,000 shares $51.42 million +23.8%5.9%2.3 $8.11 3/31/20245,120,000 shares $44.39 million -30.3%4.8%1.9 $8.67 3/15/20247,350,000 shares $56.60 million +18.6%6.9%2.8 $7.70 2/29/20246,200,000 shares $47.93 million -0.2%5.8%2.5 $7.73 2/15/20246,210,000 shares $34.03 million -9.1%5.8%2.5 $5.48 1/31/20246,830,000 shares $39.61 million +3.0%6.4%2.9 $5.80 1/15/20246,630,000 shares $43.16 million +8.5%6.2%2.8 $6.51 12/31/20236,110,000 shares $40.02 million +2.2%5.6%2.3 $6.55 12/15/20235,980,000 shares $37.26 million +0.8%5.5%2.3 $6.23 11/30/20235,930,000 shares $30.24 million -18.5%5.4%2.3 $5.10 11/15/20237,280,000 shares $37.78 million -4.7%6.7%2.8 $5.19 10/31/20237,640,000 shares $52.41 million -1.8%7.1%3 $6.86 10/15/20237,780,000 shares $60.45 million +2.1%7.2%3 $7.77 9/30/20237,620,000 shares $76.20 million +23.1%7.1%3.1 $10.00 9/15/20236,190,000 shares $64.75 million -1.1%5.7%2.6 $10.46Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 8/31/20236,260,000 shares $64.73 million -1.0%5.8%2.6 $10.34 8/15/20236,320,000 shares $65.60 million +12.1%5.8%2.6 $10.38 7/31/20235,640,000 shares $63.79 million +5.8%5.2%1.8 $11.31 7/15/20235,330,000 shares $68.17 million +31.6%4.9%1.9 $12.79 6/30/20234,050,000 shares $50.34 million -17.7%3.7%1.5 $12.43 6/15/20234,920,000 shares $65.93 million -22.2%4.5%1.9 $13.40 5/31/20236,320,000 shares $81.15 million -13.1%5.8%2.6 $12.84 5/15/20237,270,000 shares $109.05 million +21.2%6.7%3.2 $15.00 4/30/20236,000,000 shares $82.74 million +27.1%5.6%3.7 $13.79 4/15/20234,720,000 shares $66.60 million -6.9%4.4%3.8 $14.11 3/31/20235,070,000 shares $71.03 million +5.6%4.7%4 $14.01 3/15/20234,800,000 shares $74.50 million -10.6%4.5%3.5 $15.52 2/28/20235,370,000 shares $79.21 million +17.5%5.0%3.3 $14.75 2/15/20234,570,000 shares $69.60 million -9.9%4.2%2.9 $15.23 1/31/20235,070,000 shares $74.33 million -1.4%4.7%2.8 $14.66 1/15/20235,140,000 shares $71.09 million -3.8%4.7%2.6 $13.83 12/30/20225,340,000 shares $76.42 million +32.2%4.9%2.4 $14.31 12/15/20224,040,000 shares $60.64 million -31.1%3.7%1.8 $15.01 11/30/20225,860,000 shares $87.20 million -19.4%5.4%2.8 $14.88 11/15/20227,270,000 shares $108.98 million +16.0%6.7%3.5 $14.99 10/31/20226,270,000 shares $104.08 million +40.3%5.8%3.4 $16.60 10/15/20224,470,000 shares $86.18 million -12.4%4.1%2.6 $19.28 9/30/20225,100,000 shares $130.20 million -3.4%4.7%3 $25.53 9/15/20225,280,000 shares $126.19 million -2.8%4.9%3.9 $23.90 8/31/20225,430,000 shares $113.32 million -8.1%5.0%4.4 $20.87 8/15/20225,910,000 shares $159.22 million -9.9%5.4%4.8 $26.94 7/31/20226,560,000 shares $171.15 million +9.3%6.0%4.9 $26.09 7/15/20226,000,000 shares $149.64 million -2.1%5.5%4.3 $24.94 6/30/20226,130,000 shares $174.15 million +32.7%5.6%4.3 $28.41 6/15/20224,620,000 shares $123.86 million +17.9%4.3%3 $26.81 5/31/20223,920,000 shares $122.11 million -18.2%3.6%2.5 $31.15 5/15/20224,790,000 shares $160.66 million +1.1%4.4%2.3 $33.54 4/30/20224,740,000 shares $145.66 million -4.4%4.3%2.1 $30.73 4/15/20224,960,000 shares $178.31 million -6.8%4.5%2.2 $35.95 3/31/20225,320,000 shares $187.64 million -22.1%4.9%2.3 $35.27 3/15/20226,830,000 shares $262.68 million -18.6%6.3%3.3 $38.46 2/28/20228,390,000 shares $327.80 million +46.9%7.7%4.1 $39.07 2/15/20225,710,000 shares $176.55 million +0.7%5.2%2.9 $30.92 1/31/20225,670,000 shares $163.98 million +24.1%5.2%3.7 $28.92 1/15/20224,570,000 shares $138.61 million +17.5%5.7%3 $30.33 12/31/20213,890,000 shares $162.99 million +25.9%4.8%2.7 $41.90 12/15/20213,090,000 shares $123.54 million +4.4%3.8%1.9 $39.98 11/30/20212,960,000 shares $135.98 million -3.3%3.7%1.4 $45.94 11/15/20213,060,000 shares $113.10 million -10.8%3.8%1.6 $36.96 10/29/20213,430,000 shares $145.05 million +44.7%4.4%1.8 $42.29 10/15/20212,370,000 shares $87.90 million -38.1%3.0%1.4 $37.09 9/30/20213,830,000 shares $187.98 million +50.2%4.9%2.4 $49.08 9/15/20212,550,000 shares $122.40 million +3.7%3.3%1.6 $48.00 8/31/20212,460,000 shares $145.58 million +34.4%3.3%1.9 $59.18 8/13/20211,830,000 shares $105.59 million -27.1%2.4%1.6 $57.70Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 7/30/20212,510,000 shares $110.36 million -7.4%3.3%2.1 $43.97 7/15/20212,710,000 shares $100.92 million -44.5%3.6%2.3 $37.24 6/30/20214,880,000 shares $203.64 million -1.0%6.5%3.9 $41.73 6/15/20214,930,000 shares $216.92 million -3.9%6.6%3.7 $44.00 5/28/20215,130,000 shares $192.58 million -3.8%6.8%3.6 $37.54 5/14/20215,330,000 shares $195.93 million +5.1%7.1%3.7 $36.76 4/30/20215,070,000 shares $193.17 million -18.0%7.1%3.6 $38.10 4/15/20216,180,000 shares $228.35 million -14.6%8.7%4.3 $36.95 3/31/20217,240,000 shares $246.09 million +40.6%10.5%4.9 $33.99 3/15/20215,150,000 shares $185.66 million +87.3%7.5%3.9 $36.05 2/26/20212,750,000 shares $88.50 million +10.0%4.0%2.2 $32.18 2/12/20212,500,000 shares $85.58 million +18.5%3.6%1.6 $34.23 1/29/20212,110,000 shares $63.41 million +18.5%3.2%1.2 $30.05 1/15/20211,780,000 shares $49.61 million No Change2.7%0.9 $27.87 MRVI Short Interest - Frequently Asked Questions What is Maravai LifeSciences' current short interest? Short interest is the volume of Maravai LifeSciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 14,240,000 shares of MRVI short. Learn More on Maravai LifeSciences' current short interest. What is a good short interest ratio for Maravai LifeSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRVI shares currently have a short interest ratio of 4.0. Learn More on Maravai LifeSciences's short interest ratio. Which institutional investors are shorting Maravai LifeSciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Maravai LifeSciences: Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Maravai LifeSciences' short interest increasing or decreasing? Maravai LifeSciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 14,240,000 shares, an increase of 2.1% from the previous total of 13,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Maravai LifeSciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Maravai LifeSciences: Denali Therapeutics Inc. (9.34%), Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Kymera Therapeutics, Inc. (11.03%), Biohaven Ltd. (7.65%), ImmunityBio, Inc. (7.79%), Harmony Biosciences Holdings, Inc. (7.46%), Twist Bioscience Co. (16.62%), Belite Bio, Inc (0.23%), Kiniksa Pharmaceuticals, Ltd. (4.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Maravai LifeSciences stock? Short selling MRVI is an investing strategy that aims to generate trading profit from Maravai LifeSciences as its price is falling. MRVI shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Maravai LifeSciences? A short squeeze for Maravai LifeSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRVI, which in turn drives the price of the stock up even further. How often is Maravai LifeSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRVI, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Denali Therapeutics Short Interest Vericel Short Interest NewAmsterdam Pharma Short Interest Kymera Therapeutics Short Interest Biohaven Short Interest ImmunityBio Short Interest Harmony Biosciences Short Interest Twist Bioscience Short Interest Belite Bio Short Interest Kiniksa Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRVI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRVI Stock Free MRVI Stock Alerts